Skip to main content

Quality Care

By HIMSS TV | 09:55 am | February 27, 2026
HIMSS26 speaker Andrew Rubin will discuss how NYU Langone Health established a service-oriented patient interaction program in its ambulatory care centers that has improved patient satisfaction.
By Adam Ang | 11:39 pm | February 26, 2026
It has demonstrated high accuracy in detecting pancreatic cancer by extracting and analysing 260,000 metabolic signals from just 500 microlitres of blood serum.
By HIMSS TV | 10:19 am | February 25, 2026
Ovatient CEO Michael Dalton recommends that states use Rural Health Transformation Program money to move beyond hospital-centric care models and supplement local health services with virtual-first primary and specialty care.
By Adam Ang | 05:50 pm | February 24, 2026
Also, Wellumio has received $4 million in pre-Series A funding to further develop its portable, AI-augmented brain scanner.
By Adam Ang | 05:50 pm | February 24, 2026
Also, an Indian sleep tech startup is headingo the United States after raising $3 million in seed funding.
By HIMSS TV | 09:58 am | February 24, 2026
General Catalyst's Dr. Stephen Klasko discusses his keynote at the Smart Health Transformation Preconference Forum at HIMSS26, where he'll outline how healthcare can become truly patient-centered by being "tailored to the individual, and made swift."
By Adam Ang | 07:33 am | February 24, 2026
A neurologist's startup has developed a foundation model, based on 60,000 hours of brain wave records, which reportedly achieved 95% accuracy in identifying epilepsy biomarkers.
By Adam Ang | 05:21 am | February 24, 2026
Rivalling OpenEvidence and DoxGPT, Heidi’s latest offering, Heidi Evidence, sets itself apart by allowing clinicians to upload their own sources and documents.
By Jessica Hagen | 10:53 am | February 23, 2026
Shannon Kennedy, healthcare innovation, technology chair and senior executive fellow at The Digital Economist, previews her upcoming HIMSS26 immersive workshop.
By HIMSS TV | 09:45 am | February 23, 2026
Shlomi Madar, CEO of SpotitEarly, discusses the company's noninvasive test using a breath sample, which is analyzed by specially trained dogs capable of identifying unique cancer-related scent signatures combined with AI technology.